ATM and sarcoma: Furthermore, treatments with curative doses of 50 Gy and 80 Gy/4F were capable of inducing growth delays and local control in primary sarcomas, but showed no enhanced cell death when comparing mice with a single ATM allele present to an ATM deletion (Moding et al. 2015).